|
BIOSKETCH |
| Name |
Dr. Sanjay Mehendale |
| |
Director,
National Institute of Epidemiology (ICMR),
R-127, Tamil Nadu Housing Board, Ayapakkam, Chennai-77
Phone: +91-44-26357469;
Fax: +91-44-26357464;
E-mail:
directorne@dataone.in
|
|
|
|
EDUCATIONAL QUALIFICATIONS |
| Degree |
Institution |
Year |
| M.B.B.S. |
University of Poona, Maharashtra, India |
1978 |
| M.D. (Preventive & Social Medicine) |
University of Poona, Maharashtra, India |
1983 |
| M.P.H. (Master of Public Health) |
Johns Hopkins University Baltimore, USA |
1995 |
|
|
|
Research Experience
|
|
1. 1980-86 : Dept. of Preventive and Social Medicine, B.J. Medical College, Pune
2. 1986-92 : National Institute of Virology
* Epidemiology of viral diseases
* Japanese encephalitis
* Dengue fever
* Hepatitis viruses
* Measles
* Outbreak investigation
3. 1992-Dec'2010 : National AIDS Research Institute
4. Dec'2010 to Till date : National Institute of Epidemiology
|
| Areas of Interest |
-
Epidemiology of HIV/ AIDS:
* Sero-epidemiological surveys
* Surveillance
* Cohort studies
* HIV disease burden estimation
* Care provider studies
* Risk factors in HIV transmission
Clinical studies:
* HIV-STI interaction
* HIV-TB interaction
* Clinical progression of HIV infection
* Neuro-AIDS
Clinical trials:
* Vaginal microbicides
* HIV vaccine
* Anti-retroviral drugs in HIV prevention and treatment
* Community preparedness and willingness to participate in clinical trials
Socio-behavioral studies:
* Cohort recruitment and retention
* Adolescent sexuality
* Standard of care
* Ethical issues
* Psychosocial stressors in HIV infection
Teaching/ academic interests:
* Epidemiology
* Research methodology
* Ethics in bio-medical research
* Clinical trials
* Community organization and involvement in bio-medical research
* Good clinical practice
|
|
|
|
|
Grant Support & Projects:
|
Sr.No.:- 1
Project Name:- Preparation for AIDS vaccine evaluation (PAVE)
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 1992-94
Role:- Study Coordinator
Sr.No.:- 2
Project Name:- HIV Network for Preparation Trial (HIVNET)
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 1994-97
Role:- Principal Investigator
Sr.No.:- 3
Project Name:- Vaginal Microbicide Study
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 1997-99
Role:- Principal Investigator
Sr.No.:- 4
A]
Project Name:- HPTN 034 – HPTN HIV
Incidence & Participant Retention
Protocol, Pune India
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2002-03
Role:- Principal Investigator
Budget (US $):- 178,396/-
B]
Project Name:- HPTN 034 – HPTN HIV
Incidence & Participant Retention
Protocol, Pune India
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2003-04
Role:- Principal Investigator
Budget (US $):- 309,203/-
C]
Project Name:- HPTN 034 – HPTN HIV
Incidence & Participant Retention
Protocol, Pune India
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2004-05
Role:- Principal Investigator
Budget (US $):- 311,664/-
Sr.No.:- 5
A]
Project Name:- HPTN 052 – A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care Versus HIV Primary Care Alone to Prevent the Heterosexual Transmission of HIV-I in Serodiscordant Couples
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2002-03
Role:- Principal Investigator
Budget (US $):- 509,208/-
B]
Project Name:- HPTN 052 – A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care Versus HIV Primary Care Alone to Prevent the Heterosexual Transmission of HIV-I in Serodiscordant Couples
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- July 2003 to December 2004
Role:- Principal Investigator
Budget (US $):- 429,610/-
C]
Project Name:- HPTN 052 – A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy plus HIV Primary Care Versus HIV Primary Care Alone to Prevent the Heterosexual Transmission of HIV-I in Serodiscordant Couples
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2004-2005
Role:- Principal Investigator
Budget (US $):- 644,302/-
Sr.No.:- 6
A]
Project Name:- HPTN 047 – Phase I Safety and Acceptability Study of the Investigational Vaginal Microbicide PRO 2000/5 Gel (P)
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- July 2002 to June 2003
Role:- Co-Investigator
Budget(US $):- 41,310/-
B]
Project Name:- HPTN 047 – Phase I Safety and Acceptability Study of the Investigational Vaginal Microbicide PRO 2000/5 Gel (P)
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- July to 2003 to Dec.2003
Role:- Co-Investigator
Budget(US $):- 10,660/-
Sr.No.:- 7
Project Name:- HPTN (Contract) - HIV Prevention Trial Network
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2002-03
Role:- Principal Investigator
Budget (US $):- 219,126/-
Sr.No.:- 8
Project Name:- HPTN (Infra)- HIV Prevention Trial Unit
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health (NIH)USA
Duration:- 2002-03
Role:- Principal Investigator
Budget (US $):- 205,693/-
Sr.No.:- 9
Project Name:- Praneem Polyherbal Formulations(Phase II VIM) (PRANEEM)
Funding Agency:-National AIDS Control Organization,New Delhi
Duration:- 2001-2004
Role:- Principal Investigator
Sr.No.:- 10
Project Name:- Pilot Study on Acceptability of Vaginal Microbicides: Development and Validation of Acceptability MeasuresM)
Funding Agency:-National AIDS Control Organization,New Delhi
Duration:- 2001-2004
Role:- Principal Investigator
Budget (US $):- 28,554/-
Sr.No.:- 11
A]
Project Name:- Phase 1 AAV HIV-1C Vaccine Trial
Funding Agency:- International AIDS Vaccine Initiative (IAVI) USA
Duration:- 2003-04
Role:- Principal Investigator
B]
Project Name:- Phase 1 AAV HIV-1C Vaccine Trial
Funding Agency:- International AIDS Vaccine Initiative (IAVI) USA
Duration:- 2004-05
Role:- Principal Investigator
Sr.No.:- 12
Project Name:- Female Condom Study Funding Agency:- Department of Biotechnology,New Delhi
Duration:- 2001-02
Role:- Principal Investigator
Sr.No.:- 13
A]
Project Name:- Cervical cancer screening study
Funding Agency:- National Cancer Insittute, NIH, USA
Duration:- 2005-06
Role:- Principal Investigator
Budget (US $):- 43,000/-
B]
Project Name:- Cervical cancer screening study
Funding Agency:- National Cancer Insittute, NIH, USA
Duration:- 2005-06
Role:- Principal Investigator
Budget (US $):- 22,000/-
Sr.No.:- 14
Project Name:- Clinical Trials Unit – NARI, Pune, India
Funding Agency:-National Institute of Allergic & Infections Diseases (NIAID)
National Institutes of Health(NIH)USA
Duration:- 2006-13
Role:- Principal Investigator
Budget (US $):- 1.8 million approx per year
|
|
Papers published /
presented
|
> 106 in National and International journals. |
|
|
|
|
|
|